Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study of the Effectiveness of Selective Plasma Adsorption of Extracellular DNA as a Method for Preventing Intraoperative Metastasis in Pancreatic Cancer

NCT06967662 is registered in ClinicalTrials.gov with Ilyinskaya Hospital, JSC as lead sponsor.

NCT NCT06967662
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06967662 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study of the Effectiveness of Selective Plasma Adsorption of Extracellular DNA as a Method for Preventing Intraoperative Metastasis in Pancreatic Cancer
Lead sponsor
Ilyinskaya Hospital, JSC
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
April 4, 2025
Completion date
April 4, 2027
Enrollment
28 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic ductal adenocarcinoma (pdac)